vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Bluerock Homes Trust, Inc. (BHM). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $18.9M, roughly 1.1× Bluerock Homes Trust, Inc.). Bluerock Homes Trust, Inc. runs the higher net margin — -50.1% vs -541.1%, a 490.9% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 35.9%). Bluerock Homes Trust, Inc. produced more free cash flow last quarter ($10.4M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 30.1%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Bluerock Homes Trust, Inc. is a U.S.-headquartered real estate investment trust that acquires, owns and operates a portfolio of high-quality single-family rental residential properties. It caters to middle-market renters across high-growth suburban markets, prioritizing regions with strong demographic fundamentals and sustained rental housing demand.
AGIO vs BHM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $18.9M |
| Net Profit | $-108.0M | $-9.5M |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | -48.8% |
| Net Margin | -541.1% | -50.1% |
| Revenue YoY | 86.1% | 35.9% |
| Net Profit YoY | -11.9% | -29.9% |
| EPS (diluted) | $-1.86 | $-0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $18.9M | ||
| Q3 25 | $12.9M | $16.6M | ||
| Q2 25 | $12.5M | $16.8M | ||
| Q1 25 | $8.7M | $16.4M | ||
| Q4 24 | $10.7M | $13.9M | ||
| Q3 24 | $9.0M | $12.7M | ||
| Q2 24 | $8.6M | $12.5M | ||
| Q1 24 | $8.2M | $11.2M |
| Q4 25 | $-108.0M | $-9.5M | ||
| Q3 25 | $-103.4M | $-10.0M | ||
| Q2 25 | $-112.0M | $-5.8M | ||
| Q1 25 | $-89.3M | $-7.3M | ||
| Q4 24 | $-96.5M | $-7.3M | ||
| Q3 24 | $947.9M | $3.5M | ||
| Q2 24 | $-96.1M | $-5.2M | ||
| Q1 24 | $-81.5M | $-3.2M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | -48.8% | ||
| Q3 25 | -907.4% | -57.6% | ||
| Q2 25 | -1020.1% | -30.9% | ||
| Q1 25 | -1222.0% | -42.6% | ||
| Q4 24 | -1165.3% | -52.8% | ||
| Q3 24 | -1146.9% | 27.9% | ||
| Q2 24 | -1228.3% | -41.3% | ||
| Q1 24 | -1124.3% | -28.4% |
| Q4 25 | -541.1% | -50.1% | ||
| Q3 25 | -803.1% | -60.0% | ||
| Q2 25 | -899.4% | -34.7% | ||
| Q1 25 | -1023.3% | -44.7% | ||
| Q4 24 | -899.6% | -52.8% | ||
| Q3 24 | 10574.7% | 27.9% | ||
| Q2 24 | -1115.7% | -41.3% | ||
| Q1 24 | -995.8% | -28.4% |
| Q4 25 | $-1.86 | $-0.75 | ||
| Q3 25 | $-1.78 | $-0.94 | ||
| Q2 25 | $-1.93 | $-0.66 | ||
| Q1 25 | $-1.55 | $-0.67 | ||
| Q4 24 | $-1.44 | $-0.65 | ||
| Q3 24 | $16.22 | $0.24 | ||
| Q2 24 | $-1.69 | $-0.42 | ||
| Q1 24 | $-1.45 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $169.6M |
| Total DebtLower is stronger | — | $428.4M |
| Stockholders' EquityBook value | $1.2B | $128.7M |
| Total Assets | $1.3B | $1.2B |
| Debt / EquityLower = less leverage | — | 3.33× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $169.6M | ||
| Q3 25 | $92.7M | $2.1M | ||
| Q2 25 | $80.9M | $4.2M | ||
| Q1 25 | $79.0M | $3.0M | ||
| Q4 24 | $76.2M | $115.2M | ||
| Q3 24 | $253.7M | $155.1M | ||
| Q2 24 | $84.5M | $116.0M | ||
| Q1 24 | $118.8M | $92.3M |
| Q4 25 | — | $428.4M | ||
| Q3 25 | — | $415.9M | ||
| Q2 25 | — | $338.6M | ||
| Q1 25 | — | $336.5M | ||
| Q4 24 | — | $373.8M | ||
| Q3 24 | — | $122.5M | ||
| Q2 24 | — | $119.7M | ||
| Q1 24 | — | $120.2M |
| Q4 25 | $1.2B | $128.7M | ||
| Q3 25 | $1.3B | $131.7M | ||
| Q2 25 | $1.4B | $135.3M | ||
| Q1 25 | $1.5B | $137.1M | ||
| Q4 24 | $1.5B | $139.1M | ||
| Q3 24 | $1.6B | $142.9M | ||
| Q2 24 | $660.5M | $142.5M | ||
| Q1 24 | $743.9M | $144.5M |
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.4B | $222.1M | ||
| Q2 25 | $1.5B | $220.3M | ||
| Q1 25 | $1.6B | $186.2M | ||
| Q4 24 | $1.7B | $967.0M | ||
| Q3 24 | $1.8B | $800.8M | ||
| Q2 24 | $773.1M | $756.2M | ||
| Q1 24 | $849.7M | $727.4M |
| Q4 25 | — | 3.33× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | 2.50× | ||
| Q1 25 | — | 2.45× | ||
| Q4 24 | — | 2.69× | ||
| Q3 24 | — | 0.86× | ||
| Q2 24 | — | 0.84× | ||
| Q1 24 | — | 0.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $27.8M |
| Free Cash FlowOCF − Capex | $-97.3M | $10.4M |
| FCF MarginFCF / Revenue | -487.5% | 55.0% |
| Capex IntensityCapex / Revenue | 5.6% | 91.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $25.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $27.8M | ||
| Q3 25 | $-88.2M | $13.4M | ||
| Q2 25 | $-77.1M | $13.9M | ||
| Q1 25 | $-111.5M | $951.0K | ||
| Q4 24 | $-133.2M | $9.1M | ||
| Q3 24 | $-84.2M | $1.7M | ||
| Q2 24 | $-72.6M | $1.3M | ||
| Q1 24 | $-99.9M | $1.1M |
| Q4 25 | $-97.3M | $10.4M | ||
| Q3 25 | $-89.7M | $8.7M | ||
| Q2 25 | $-78.0M | $8.8M | ||
| Q1 25 | $-112.3M | $-2.9M | ||
| Q4 24 | $-134.1M | $-253.0K | ||
| Q3 24 | $-84.6M | $-601.0K | ||
| Q2 24 | $-72.7M | $-654.0K | ||
| Q1 24 | $-100.0M | $-630.0K |
| Q4 25 | -487.5% | 55.0% | ||
| Q3 25 | -696.5% | 52.4% | ||
| Q2 25 | -626.2% | 52.2% | ||
| Q1 25 | -1286.4% | -17.6% | ||
| Q4 24 | -1250.1% | -1.8% | ||
| Q3 24 | -944.2% | -4.7% | ||
| Q2 24 | -844.4% | -5.2% | ||
| Q1 24 | -1221.2% | -5.6% |
| Q4 25 | 5.6% | 91.8% | ||
| Q3 25 | 12.1% | 28.5% | ||
| Q2 25 | 7.0% | 30.3% | ||
| Q1 25 | 8.8% | 23.4% | ||
| Q4 24 | 9.0% | 66.9% | ||
| Q3 24 | 4.7% | 18.0% | ||
| Q2 24 | 1.8% | 15.3% | ||
| Q1 24 | 1.7% | 15.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | 0.47× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
BHM
| Residential Communities Segment | $11.4M | 61% |
| Scattered Single Family Homes Segment | $7.5M | 39% |
